In compliance with current regulations, let us know which audience you belong to:
Light Modulation™
The power of light, cubed.
LM™ Low-level Light Therapy is a unique, light-based photobiomodulation technology. We developed and patented for medical use the technology originally employed by NASA to treat wounds of astronauts in space.
LM™ LLLT has nothing to do with Red Light Therapy (RLT), which only acts on the surface of the dermis—instead, LM™ LLLT works at biological level, generating endogenous heat through powerful LEDs stimulating ATP production in cells.
Photobiomodulation therapy with LM™ LLLT is a unique and completely non-invasive form of near-infrared light therapy (NILT), highly effective for treating a broad spectrum of conditions. Our patented photobiomodulation technology leverages various wavelengths to cater to diverse medical needs.
In ophthalmology, it addresses both anterior (DED, Chalazion) and posterior (dAMD) segment conditions. Additionally, LM™ LLLT extends its benefits to dermatology and trichology, ensuring versatile and effective outcomes by stimulating ATP production.
The degree of simplicity offered by LM™ LLLT technology to the operator, and the convenience hence provided to the patient benefitting from its therapy is, put simply, unmatched. This, paired with LM™ LLLT exceptional efficacy in addressing a broad spectrum of anterior and posterior segment conditions, along with dermatologic and trichologic concerns, makes it a true game-changer.
LM™ LLLT has recently been studied in a piece of research that compared it directly against IPL. The study has confirmed the efficacy of LM™ LLLT, proving also its superior performance against traditional IPL technologies.
Another recent scientific paper has confirmed that LM™ LLLT, employed jointly with OPE™ IPL, is the key factor in effectively managing the most severe cases of recalcitrant MGD-induced DED and other ocular surface diseases.
LM™ LLLT’s potential extends beyond direct treatment of most ocular surface diseases, playing a crucial role in both cataract and refractive surgeries. Literature shows that LM™ LLLT enhances outcomes in cataract and refractive surgeries by stabilizing tear film and reducing ocular discomfort when used pre- and post-surgery. Whether we’re talking of traditional cataracts, premium IOLs or refractive, we’re certain LM™ LLLT can play a significant role in elevating any surgery. That’s why the Espansione Ecosystem, above all through LM™ LLLT, is the best option to elevate your surgery routine.
Operators and patients can enjoy the unique benefits of LM™ LLLT technology.